Table 3.
Patients with rare CNVs
affecting cardiovascular system development |
Other
patients |
|||||
---|---|---|---|---|---|---|
(n=22) | (n=811) | p-value | Adjusted p-value | OR | [95% CI] | |
---|---|---|---|---|---|---|
Age | 42.8 ± 10.4 | 44.3 ± 9.9 | 0.494 | |||
Female sex | 10 (45.5) | 343 (42.3) | 0.828 | |||
Stroke | 16 (72.7) | 522 (64.4) | 0.503 | 0.425 | 1.47 | [0.57 – 3.81] |
ICAD | 13 (59.1) | 547 (67.4) | 0.490 | 0.501 | 0.74 | [0.30 – 1.79] |
Multiple CeAD | 1 (4.5) | 124 (15.3) | 0.230 | 0.184 | 0.25 | [0.03 – 1.91] |
Hypertension | 5 (22.7 | 214 (26.6) | 0.810 | 0.815 | 0.88 | [0.31 – 2.51] |
Hypercholesterolemia | 4 (18.2) | 153 (19.3) | 1.000 | 0.955 | 1.03 | [0.33 – 3.23] |
Migraine | 9 (40.9) | 300 (37.5) | 0.824 | 0.811 | 1.12 | [0.46 – 2.72] |
BMI | 25.0 ± 6.4 | 24.6 ± 3.9 | 0.743 | 0.469 | 1.04 | [0.94 – 1.15] |
Previous trauma | 8 (36.8) | 328 (41.2) | 0.827 | 0.592 | 0.78 | [0.32 – 1.91] |
Previous infection | 7 (31.8) | 150 (18.9) | 0.165 | 0.134 | 2.02 | [0.81 – 5.04] |
smoking | 1 (50.0) | 418 (52.2) | 1.000 | 0.916 | 0.96 | [0.41 – 2.25] |
FH of CeAD | 2 (10.5) | 5 (0.7) | 0.011 | 0.001 | 18.5 | [3.3 – 103] |
FH of CeAD (unrelated) | 1 (5.6) | 4 (0.5) | 0.110 | 0.036 | 11.2 | [1.17 – 107] |